• Meropenem Workflows for Resistant Bacterial Models

  2026-08-10

  Build reproducible MIC, time-kill, resistance, and translational infection workflows around Meropenem, an ultra-broad-spectrum β-lactam antibiotic carbapenem. The article connects exposure-based assay design with Gram-negative bacterial infection models, nanoparticle research, and troubleshooting strategies for carbapenem-resistant bacterial infections.

• CX-4945 (Silmitasertib): CK2 and Cancer Stemness

  2026-08-09

  CX-4945, also known as Silmitasertib, offers a translational route from CK2 biology to cancer stemness, therapy resistance, apoptosis, and cell-cycle control. This article interprets evidence linking CK2-dependent ECE-1c stability to aggressive NSCLC phenotypes and provides a practical framework for validating CK2-driven mechanisms in cancer models.

• Meropenem in Reliable Cell and Infection Assays

  2026-08-08

  This scenario-based guide explains how Meropenem (SKU A5124) can reduce bacterial confounding in viability, proliferation, cytotoxicity, and infection-model workflows. It covers mechanism, stock preparation, concentration design, interpretation, and practical supplier selection using product specifications and relevant β-lactam literature.

• Meropenem Assay Design for Resistance Research

  2026-08-07

  Meropenem is a β-lactam antibiotic carbapenem with unusually broad activity for mechanistic infection studies. This guide presents a translational assay framework linking PBP inhibition, exposure above MIC, resistance phenotyping, and nanoparticle-based septicemia research.

• SB743921: Kinesin Spindle Protein Inhibitor in Cancer Workfl

  2026-08-07

  SB743921 stands out as a potent and selective kinesin spindle protein inhibitor, enabling precise cell cycle arrest and apoptosis in diverse cancer models. This article details practical protocols, troubleshooting insights, and unique comparative advantages—empowering advanced cancer research with evidence-backed guidance.

• Cryo-EM Reveals Hidden Conformations of Human αvβ3 Integrin

  2026-08-06

  A recent cryo-EM study of full-length human αvβ3 integrin revealed a spectrum of previously unknown conformations, deepening insight into integrin activation and informing next-generation drug design. These findings highlight the value of advanced structural workflows and careful membrane protein stabilization.

• Annexin V-FITC/PI Apoptosis Assay Kit: Protocol and Troubles

  2026-08-06

  The Annexin V-FITC/PI Apoptosis Assay Kit enables researchers to distinguish viable, early apoptotic, and late apoptotic/necrotic cells using a rapid, fluorescence-based staining protocol. It is suited for flow cytometry and fluorescence microscopy workflows requiring clear separation of cell death stages. This kit should not be used for diagnostic or clinical applications, and performance outside recommended storage or staining conditions is not validated.

• AO/PI Double Staining Kit: Practical Guide to Cell Viability

  2026-08-05

  The AO/PI Double Staining Kit enables rapid, dual-fluorescent discrimination of viable, apoptotic, and necrotic cells in cell biology assays. Designed for routine use in viability, apoptosis, and necrosis detection, it is best suited for fluorescence microscopy or flow cytometry workflows where clear identification of cell health states is essential. The kit should not be used in non-fluorescence-based assays or for applications requiring mechanistic quantification beyond membrane integrity and nuclear morphology.

• Meropenem: Experimental Workflows in Resistance Modeling

  2026-08-05

  Meropenem stands out as a robust β-lactam antibiotic carbapenem for high-fidelity modeling of Gram-negative and Gram-positive bacterial resistance. This guide delivers actionable protocol enhancements, troubleshooting insights, and comparative context for scientists driving translational research.

• MK-2206 dihydrochloride: Targeted Akt Inhibition in Cancer a

  2026-08-04

  MK-2206 dihydrochloride stands out as a potent, selective allosteric Akt inhibitor for dissecting PI3K/Akt/mTOR signaling in cancer, apoptosis, and metabolic disease models. This guide delivers advanced workflows, troubleshooting strategies, and highlights how recent glycolytic control discoveries reshape experiment design.

• FTSJ3 Loss Drives R-Loop DNA Damage and Chemosensitivity in

  2026-08-04

  This study identifies FTSJ3 as a critical regulator of R-loop homeostasis and genomic integrity in lung cancer cells. The findings reveal that FTSJ3 depletion increases R-loop-associated DNA damage and sensitizes tumor cells to cisplatin, highlighting FTSJ3 as a potential biomarker for chemotherapy responsiveness.

• Zoledronic Acid: Advanced Workflows for Cancer and Bone Dise

  2026-08-03

  Zoledronic Acid, a potent nitrogen-containing bisphosphonate from APExBIO, enables precise modeling of cancer cell apoptosis and osteolytic bone disease in preclinical studies. This guide details actionable protocol enhancements, troubleshooting strategies, and the translational impact of recent mechanistic insights, driving higher reproducibility and data quality for oncology and bone research.

• Nicotinamide Adenine Dinucleotide (NAD+): Workflow Advances

  2026-08-03

  Nicotinamide Adenine Dinucleotide (NAD+) is transforming metabolic and autophagy research, offering precise control and readout in stress signaling assays. APExBIO's NAD+ enables robust, reproducible workflows and unlocks new troubleshooting strategies for energy stress studies.

• Redefining In Vitro Drug Response Metrics in Cancer Research

  2026-08-02

  Schwartz's dissertation establishes how relative viability and fractional viability capture distinct facets of anti-cancer drug effects, challenging the longstanding practice of treating them as interchangeable. This work provides a refined methodological framework for evaluating cell cycle arrest and apoptosis, informing the rational use of mitotic inhibitors such as SB743921 in preclinical cancer models.

• Hesperadin: Precision Aurora B Kinase Inhibition in Mitosis

  2026-08-01

  Hesperadin empowers researchers to dissect mitotic progression with high specificity by targeting Aurora B kinase, making it ideal for advanced cell cycle and cancer research. This guide bridges mechanistic insight with reproducible workflows, protocol enhancements, and troubleshooting strategies, drawing on the latest literature and validated protocols.

15734 records 1/1049 page Next 12345 下5页 Last page